Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Roche Holding Ltd.    RHO5   CH0012032048

Delayed Quote. Delayed  - 07/01 06:45:32 pm
236.109 EUR   +0.07%
06/30 FOUNDATION MEDI : NCI - Significant expansion of data available in t..
06/30 ROCHE : Uch Takes Delivery of N100 Million Laboratory Equipment
06/29 FOUNDATION MEDI : Announces Release of Molecular Information from Fo..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ROCHE HOLDING LTD.
07/01 ROCHE : Diagnostics Operations Assigned Patent
06/30 FOUNDATION MEDICINE : NCI - Significant expansion of data available in the Genom..
06/30 ROCHE : Uch Takes Delivery of N100 Million Laboratory Equipment
06/29 FOUNDATION MEDICINE : Announces Release of Molecular Information from Foundation..
06/28 ROCHE : Ocrevus marketing applications under review by the EMA and FDA
06/28 ROCHE : Hetero launches colorectal cancer drug
06/28 ROCHE : FDA Grants Priority Review for Genentechs OCREVUS (ocrelizumab) Biologic..
06/28 ROCHE : marketing applications for review of OCREVUS® (ocrelizumab) in two forms..
06/28 ROCHE : marketing applications for review of Ocrevus (ocrelizumab) in two forms ..
06/28 ROCHE : FDA Grants Priority Review for Genentech’s OCREVUS™ (ocreliz..
06/25 ROCHE : Master of work on the Layouts and rehabilitation
06/24 ROCHE : Diagnostics Operations Assigned Patent
06/23 U.S. Supreme Court weighs review of canceled patent on prenatal test
06/23 ROCHE : Federal Contracts Awarded by Federal Agencies in South Dakota (June 23)
06/23 ROCHE : Nearly 10 million U.S. adults severely nearsighted
06/23 CONTRACT AWARD - 68-- NOXIOUS WEEDS : Crow creek agency
06/23 FOUNDATION MEDICINE, INC. : Submission of Matters to a Vote of Security Holders ..
06/23 ROCHE : Invitation to Roche's Half Year Results 2016
06/22 Roche CEO 'sleeps better' as risk to drugmaker's growth recedes
06/22 CHUGAI PHARMACEUTICAL : and Maruho Announce the Launch of'Marduox Ointment,' for..
06/21 ROCHE : Harbor residents concerned of drainage to Westcott Bay
06/20 FOUNDATION MEDICINE : Shorted Shares Increased 0.65% After Market Selling
06/20 ROCHE : launches the new cobas e 801 module, helping hospitals meet the demand f..
06/20 Novartis aims to triple biosimilar drugs by 2020
06/20 ALLERGAN : 1 Stock to Invest in Big Pharma
06/16 CANCER TREATMENT : Patent Issued for Predictive Biomarker for Cancer Treatment w..
06/16 FOUNDATION MEDICINE : Data From a Study Utilizing FoundationOne® Heme Indicates ..
06/16 Foundation Medicine Presents New Data at ASCO 2016 Demonstrating that Foundat..
06/16 Foundation Medicine and AstraZeneca Enter Strategic Collaboration for Lynparz..
06/16 ROCHE : EC approves Gazyvaro plus bendamustine in follicular lymphoma
06/16 ROCHE : employees raise funds for vulnerable children in over 90 communities aro..
06/16 ROCHE : Gazyvaro approved in Europe in combination with bendamustine for people ..
06/14 ROCHE : Tecentriq to dominate the bladder cancer market, says GlobalData
06/13 GOOD PHARMA : How Marketing creates Value in Pharma
06/11 RELIANCE : Life rolls out first copies of roche's avastin
06/10 ROCHE : Silicon Valley pioneer Thomas Perkins dies
06/09DJMERCK : to Acquire Biotech Company Afferent
06/09 CHUGAI PHARMACEUTICAL : Announces License Agreement for Recycling Antibody SA237
06/09 FOUNDATION MEDICINE : to Present at the Goldman Sachs Annual Healthcare Conferen..
06/09 ROCHE : MILITARY $62,888 Federal Contract Awarded to Roche Diagnostics
06/09 ARRAY BIOPHARMA : Genentech Assigned Patent
06/09 EMPIRES AND SPLENDOUR : David Roche's private collection of antiques opens to pu..
06/08 ASTELLAS PHARMA : Genentech, OSI to pay $67M over cancer drug allegations
06/08 ROCHE : EC approves Avastin plus Tarceva in NSCLC
06/08 FOUNDATION MEDICINE : Susan Hager, VP at Foundation Medicine to Present at Inaug..
06/08 ROCHE : receives EU approval of Avastin in combination with Tarceva for patients..
06/08 ROCHE : immunotherapy and personalised medicines at American Society of Clinical..
06/08 BREAST CANCER DRUG : Mylan, biocon upbeat on trial data
06/07 ASTELLAS PHARMA : Genentec, OSI Pharma to pay $67M to resolve Tarceva false clai..
06/07 ROCHE : Phase III Study Shows Genentech's Actemra (tocilizumab) Maintained Stero..
06/07 FOUNDATION MEDICINE : New Data from Foundation Medicine and Collaborators Suppor..
06/07 ROCHE : Pharmaceutical Companies to Pay $67 Million To Resolve False Claims Act ..
06/07 ASTELLAS PHARMA : Genentech, OSI to pay $67M over cancer drug allegations
06/07 GENENTECH, OSI TO PAY $67 MILLION OV : U.S. Justice Dept
06/06 ROCHE : Genentechs Cancer Immunotherapy TECENTRIQ (Atezolizumab) Shrank Tumors i..
06/06 FOUNDATION MEDICINE : Presents New Data at ASCO 2016 Demonstrating that Foundati..
06/06 ROCHE : Genentech's Cancer Immunotherapy Tecentriq (Atezolizumab) Shrank Tumors ..
06/06 Foundation Medicine Enters into Agreement with AstraZeneca
06/06 ROCHE : cancer immunotherapy Tecentriq (atezolizumab) shrank tumours in people w..
06/06 ROCHE : Phase III study shows Roche's Actemra/RoActemra maintained steroid-free ..
06/06 ROCHE : Phase III study shows Roche’s Actemra/RoActemra maintained steroid..
06/06 ROCHE : Phase III Study Shows Genentech’s Actemra® (tocilizumab) Maintaine..
06/06 ROCHE : Pharmaceutical Companies To Pay $67 Million To Resolve False Claims Act ..
06/05DJCombination Drug Therapies for Cancer Show Promise at Higher Potential Cost
06/05 ROCHE : cancer immunotherapy Tecentriq (atezolizumab) shrank tumours in people w..
06/05 GENENTECH : ’s Cancer Immunotherapy TECENTRIQ™ (Atezolizumab) Shrank..
06/04 FOUNDATION MEDICINE : FoundationOne Identifies Patients with Advanced Lung Cance..
06/04 ROCHE : Tecentriq® (atezolizumab) shows increasing overall survival benefit in u..
06/04 ROCHE : showcases three distinct combinations for cancer immunotherapy treatment..
06/03DJROCHE : Study Finds Mylan's 'Biosimilar' Drug Comparable to Roche Cancer Medicin..
06/03DJROCHE : Study Finds Mylan's 'Biosimilar' Drug Comparable to Roche Cancer Medicin..
06/03 ACHAOGEN : Adds Tobin Schilke as Chief Financial Officer
06/02 CHUGAI PHARMACEUTICAL : Osaka University and Chugai tie up for further advanceme..
05/31 ROCHE : to invest $60M, expand plant in Puerto Rico
05/31 ROCHE : EC approves MabThera for chronic lymphocytic leukaemia
1  2  3  4  5  6  7  8  9  10Next
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials